Start › Rak piersi › Minnesota › Minneapolis
Badania kliniczne dla Rak piersi w mieście Minneapolis, MN
27 badań dla Rak piersi szuka uczestników w ośrodkach w mieście Minneapolis i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- Minneapolis VA Medical Center, Minneapolis
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekrutacjaFaza 3
- Minnesota Oncology Hematology, P.A., Minneapolis
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekrutacjaFaza 3
- Minnesota Oncology Hematology P A, Minneapolis
- Allina Hlth Cancer Inst Minneapolis, Minneapolis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mi dalej
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekrutacjaFaza 2
- University of Minnesota, Masonic Cancer Center, Minneapolis
PRE-ISPY Phase I/II Oncology Platform Program
RekrutacjaFaza 1/2
- University of Minnesota Masonic Cancer Center, Minneapolis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekrutacjaFaza 2
- HealthPartners Frauenshuh Cancer Center, Saint Louis Park · 5 mi dalej
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekrutacjaFaza 3
- Clinical Trial Site, Minneapolis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekrutacjaFaza 3
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Metro-Minnesota Community Clinical Oncology, Saint Louis Park · 5 mi dalej
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekrutacjaFaza 3
- Healthpartners Regions Specialty Clinics, Saint Louis Park · 5 mi dalej
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekrutacjaFaza 3
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Metro-MN Comm. Onc. Res Consortium, Saint Louis Park · 5 mi dalej
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekrutacjaFaza 3
- University of Minnesota Medical Center, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekrutacjaFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekrutacjaFaza 2/3
- Local Institution - 0372, Minneapolis
Fast-Her: Fasting Effects on Breast Cancer Treatment
Rekrutacja
- University of Minnesota, Minneapolis
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekrutacjaFaza 3
- Allina Health System DBA Virginia Piper Cancer Institute, Minneapolis
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekrutacjaFaza 2
- University of Minnesota, Minneapolis
- Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park · 5 mi dalej
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekrutacjaFaza 3
- Minnesota Oncology Hematology, P.A., Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
RekrutacjaFaza 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 mi dalej
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekrutacjaFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Allina Health Cancer Institute, Minneapolis
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekrutacjaBadanie obserwacyjne
- Metro Minnesota Community Oncology Consortium (MMCORC), Saint Louis Park · 5 mi dalej
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekrutacjaFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi dalej
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekrutacjaBadanie obserwacyjne
- Minnesota Oncology, Minneapolis
Badania dla Rak piersi w innych miastach
- New York City, NY136 badań
- Houston, TX126 badań
- Boston, MA112 badań
- Nashville, TN81 badań
- Los Angeles, CA73 badań
- Edison, NJ68 badań
- St. Louis, MO64 badań
- Queens, NY64 badań
- Durham, NC64 badań
- Chicago, IL59 badań
- Philadelphia, PA56 badań
- Dallas, TX55 badań
Inne badania w mieście Minneapolis
- Niedrobnokomórkowy rak płuca27 badań
- Rak jajnika24 badań
- Rak prostaty23 badań
- Nowotwory (wszystkie typy)22 badań
- Niewydolność serca21 badań
- Ostra białaczka szpikowa20 badań
- Rak płuc20 badań
- Rak jelita grubego i odbytnicy19 badań
- Rak endometrium18 badań
- Choroba Parkinsona17 badań
- Choroby układu sercowo-naczyniowego15 badań
- Choroba wieńcowa13 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.